A/H1N1 flu vaccine put into production
A/H1N1 flu vaccine is formally put into production by China's domestic pharmaceuticalcompany Sinovac Biotech Ltd., also known as Beijing Kexing Bioproducts, Sep.3, 2009.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health in the US, has revealed that the early data from these trials suggest that 2009 H1N1 influenza vaccines are well tolerated, and induce a strong immune response in most healthy adults, when administered in a single unadjuvanted 15-microgram dose.